Kepos Capital LP Virpax Pharmaceuticals, Inc. Transaction History

Kepos Capital LP

  • $228 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$1.22 - $2.25 $915,000 - $1.69 Million
-750,000 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$4.14 - $22.9 $3.1 Million - $17.2 Million
750,000 New
750,000 $3.6 Million

About Virpax Pharmaceuticals, Inc.

VRPX Quotes by TradingView
  • Ticker VRPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,714,600
  • Market Cap $3.87M
  • Description
  • Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...
More about VRPX
Track This Portfolio

Track Kepos Capital LP Portfolio

Follow Kepos Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Kepos Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email